Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

What's In The Cards For Expedia Group's (EXPE) Q2 Earnings?

Published 07/24/2019, 09:14 PM
Updated 07/09/2023, 06:31 AM

Expedia Group, Inc. (NASDAQ:EXPE) is scheduled to report second-quarter 2019 results on Jul 30.

The company outpaced the Zacks Consensus Estimate in all the trailing four quarters, with the average being 26.92%.

In the last reported quarter, revenues increased 4% year over year and 1.9% on a sequential basis to $2.61 billion. However, the figure missed the Zacks Consensus Estimate of $2.69 billion.

Robust performance of Vrbo, which was previously known as HomeAway, Brand Expedia and Expedia Partner Solutions should drive the upcoming results. Moreover, strong segmental performance will likely help the stock to perform well.

Let’s see how things are shaping up for the upcoming quarterly results.

Core OTA

Strength in growing stayed room night number and overall gross bookings will likely drive the segment’s results in the to-be-reported quarter.

The Zacks Consensus Estimate for the segment’s revenues is currently pegged at $2.47 billion.

Vrbo

Rising conversion rates and strong focus on improvisation of instant book ability are anticipated to drive its top line in the soon-to-be-reported quarter. Further, a consistent increase in stayed room nights and property nights is likely to contribute to listings on Vrbo in the quarter.

The Zacks Consensus Estimate for revenues is pegged at $334 million.

Egencia

The segment is expected to perform well in the to-be-reported quarter, backed by the ramp up of Egencia's sales force and growing clientele. Further, Egencia’s offering of differentiated products will likely sustain its momentum in the corporate travel market.

The Zacks Consensus Estimate for the segment’s revenues is pegged at $166 million.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Trivago

Expedia’s continued efforts to increase alternative accommodation listings on the trivago platform are expected to aid the top line. However, unfavorable changes in marketplaces served by the company could affect this segment.

What Our Model Says

According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. Expedia has the right mix, as you will see below.

It currently has a Zacks Rank #2 and an Earnings ESP of +3.21%.

Sell-rated stocks (Zacks Rank #4 or 5) are best avoided. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Other Stocks to Consider

Here are some other stocks that you may also want to consider, as our model shows that these too have the right combination of elements to post an earnings beat in the to-be-reported quarter.

Amazon.com, Inc. (NASDAQ:AMZN) has an Earnings ESP of +4.01% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Facebook, Inc. (NASDAQ:FB) has an Earnings ESP of +0.61% and a Zacks Rank #2.

Thermo Fisher Scientific Inc. (NYSE:TMO) has an Earnings ESP of +0.54% and holds a Zacks Rank #3.

This Could Be the Fastest Way to Grow Wealth in 2019

Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.

Click here to see these breakthrough stocks now >>



Expedia Group, Inc. (EXPE): Free Stock Analysis Report

Amazon.com, Inc. (AMZN): Free Stock Analysis Report

Facebook, Inc. (FB): Free Stock Analysis Report

Thermo Fisher Scientific Inc. (TMO): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.